Unknown PHASE4 INTERVENTIONAL 3-arm NCT01010516

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia

Sponsor: University of Ioannina

Interventions High-dose rosuvastatin Statin plus fenofibrate Statin plus niacin ER/laropiprant

Updated 5 times since 2017 Last updated: Aug 9, 2011 Started: Oct 31, 2009 Primary completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01010516, this PHASE4 trial focuses on Dyslipidemia and remains ongoing. Sponsored by University of Ioannina, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Ioannina

Data source: University of Ioannina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ioannina, Greece